Formulation and evaluation of thienorphine hydrochloride sublingual delivery system

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 12, 2012, Pages 1479-1486

  Liu, Fei ^a,b   Zhao, Yumei ^a   Sun, Jianxu ^a   Gao, Yongliang ^a   Zhang, Zhenqing ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b Department of Pharmacy   (China)

Author keywords

Absorption; Bioavailability; Cyclodextrin; Solubility; Sublingual drug delivery; Thienorphine

Indexed keywords

CYCLODEXTRIN; DIMETHYL BETA CYCLODEXTRIN; OPIATE AGONIST; THIENORPHINE HYDROCHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT; X RAY DIFFRACTION;

ADMINISTRATION, SUBLINGUAL; ANIMALS; BETA-CYCLODEXTRINS; BUPRENORPHINE; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DELIVERY SYSTEMS; INTESTINAL MUCOSA; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; PERMEABILITY; RATS; RATS, WISTAR; SOLUBILITY; X-RAY DIFFRACTION;

EID: 84871222397     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c12-00508     Document Type: Article

References (38)

1. Yu G., Yue Y. J., Cui M. X., Gong Z. H., J. Pharmacol. Exp. Ther., 318, 282-287 (2006).
2. Li J. X., Becker G. L., Traynor J. R., Gong Z. H., France C. P., J. Pharmacol. Exp. Ther., 321, 227-236 (2007).
3. Johnson R. E., Strain E. C., Amass L., Drug Alcohol Depend., 70 (Suppl.), S59-S77 (2003).
4. Kong Q., Qiao J., Wang X., Yuan S., Zhang Z., Gong Z., Ruan J., J. Chromatogr. B, 859, 52-61 (2007).
5. Madhav N. V., Shakya A. K., Shakya P., Singh K., J. Controlled Release, 140, 2-11 (2009).
6. Veuillez F., Kalia Y. N., Jacques Y., Deshusses J., Buri P., Eur. J. Pharm. Biopharm., 51, 93-109 (2001).
7. Loftsson T., Vogensen S. B., Brewster M. E., Konrádsdóttir F., J. Pharm. Sci., 96, 2532-2546 (2007).
8. Bellia F., La Mendola D., Pedone C., Rizzarelli E., Saviano M., Vecchio G., Chem. Soc. Rev., 38, 2756-2781 (2009).
9. Matsuda H., Arima H., Adv. Drug Deliv. Rev., 36, 81-99 (1999).
10. Yavuz B., Bilensoy E., Vural I., Sumnu M., Int. J. Pharm., 398, 137-145 (2010).
11. García-Río L., Hall R. W., Mejuto J. C., Rodriguez-Dafonte P., Tetra hedron, 63, 2208-2214 (2007).
12. Ohtani Y., Irie T., Uekama K., Fukunaga K., Pitha J., Eur. J. Biochem., 186, 17-22 (1989).
13. Hussain A., Yang T., Zaghloul A. A., Ahsan F., Pharm. Res., 20, 1551-1557 (2003).
14. Merkus F. W., Verhoef J. C., Marttin E., Romeijn S. G., van der Kuy P. H., Hermens W. A., Schipper N. G., Adv. Drug Deliv. Rev., 36, 41-57 (1999).
15. Higuchi T., Connors K. A., Advances in Analytical Chemistry and Instrumentation, 4, 117-212 (1965).
16. Heaney T. G., Jones R. S., Arch. Oral Biol., 23, 713-717 (1978).
17. Squier C. A., Cox P., Wertz P. W., J. Invest. Dermatol., 96, 123-126 (1991).
18. Cappello B., De Rosa G., Giannini L., La Rotonda M. I., Mensitieri G., Miro A., Quaglia F., Russo R., Int. J. Pharm., 319, 63-70 (2006).
19. Veuillez F., Rieg F. F., Guy R. H., Deshusses J., Buri P., Int. J. Pharm., 231, 1-9 (2002).
20. De Caro V., Giandalia G., Siragusa M. G., Paderni C., Campisi G., Giannola L. I., Eur. J. Pharm. Biopharm., 70, 869-873 (2008).
21. Frijlink H. W., Schoonen A. J. M., Lerk C. F., Int. J. Pharm., 49, 91-102 (1989).
22. Vianna R., Bentley M., Ribeiro G., Carvalho F., Neto A., Oliveira D., Collett J., Int. J. Pharm., 167, 205-213 (1998).
23. Ventura C. A., Puglisi G., Zappalà M., Mazzone G., Int. J. Pharm., 160, 163-172 (1998).
24. Cho E., Gwak H., Chun I., Int. J. Pharm., 349, 101-107 (2008).
25. Nicolazzo J. A., Reed B. L., Finnin B. C., J. Controlled Release, 105, 1-15 (2005).
26. Brewster M. E., Loftsson T., Adv. Drug Deliv. Rev., 59, 645-666 (2007).
27. Davis M. E., Brewster M. E., Nat. Rev. Drug Discov., 3, 1023-1035 (2004).
28. Loftsson T., Hreinsdóttir D., Másson M., Int. J. Pharm., 302, 18-28 (2005).
29. Kamphorst A. O., Mendes de Sá I., Faria A. M., Sinisterra R. D., Eur. J. Pharm. Biopharm., 57, 199-205 (2004).
30. Liu J., Qiu L., Gao J., Jin Y., Int. J. Pharm., 312, 137-143 (2006).
31. Vlachou M., Papaïoannou G., J. Biomater. Appl., 17, 197-206 (2003).
32. Rajewski R. A., Stella V. J., J. Pharm. Sci., 85, 1142-1169 (1996).
33. Gao L., Liu G., Wang X., Liu F., Xu Y., Ma J., Int. J. Pharm., 404, 231-237 (2011).
34. Liu J., Qiu L., Gao J., Jin Y., Int. J. Pharm., 312, 137-143 (2006).
35. Sinswat P., Tengamnuay P., Int. J. Pharm., 257, 15-22 (2003).
36. Babu R. J., Pandit J. K., Int. J. Pharm., 271, 155-165 (2004).
37. Nakanishi K., Nadai T., Masada M., Miyajima K., Chem. Pharm. Bull., 40, 1252-1256 (1992).
38. Stella V. J., Rao V. M., Zannou E. A., Zia V. V., Adv. Drug Deliv. Rev., 36, 3-16 (1999).